Tumor-reactive IgE antibodies in plasma of patients with gastrointestinal carcinomas
- PMID: 6551192
- PMCID: PMC11040939
- DOI: 10.1007/BF00205357
Tumor-reactive IgE antibodies in plasma of patients with gastrointestinal carcinomas
Abstract
A total of 208 plasma samples from 115 patients with gastrointestinal carcinomas and nine patients with other intestinal disease were examined for the presence of IgE tumor antibodies by a solid-phase radioimmunoassay. Approximately one-third of the patients gave significant reactions with gastrointestinal carcinoma extracts compared with normal tissue extracts. Absorption with tumor and normal tissue extracts, with type AB human red cells, and with CEA indicated tumor specificity in some of the samples so examined. None of the 50 serum samples tested from normal blood donors contained tumor-specific IgE. IgE tumor antibodies decreased or completely disappeared in the majority of patients 8-13 days after surgical treatment.
References
-
- Bartholomaeus WN, Keast D. Reaginic antibody to tumor and alloantigens in mice. Nature. 1972;239:206. - PubMed
-
- Berczi I, McMorris LS, Thorlakson TK, Thorlakson RH, Sehon AH. Detection of tumor antibodies in patients with gastrointestinal carcinomas by a solid-phase radioimmunoassay. J Natl Cancer Inst. 1979;63:553. - PubMed
-
- Bowen JG, Baldwin RW. Tumor-specific antigen related to rat histocompatibility antigens. Nature. 1975;258:75. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources